Use of guideline-directed medical therapy in outpatients with heart failure in real-world practice: a subanalysis of PRIORITY-HF study

Material and methods. This retrospective analysis of contraindication rate to four GDMT classes was performed in 19981 outpatients with HF included in the PRIORITYHF study. The changes of drug prescription and titration were assessed in a cohort of patients without contraindications and who underwent visits at 6 and 12 months of follow-up. The multivariate mixed logistic regression was used to determine factors associated with the prescription and higher doses of GDMT drugs. R e sults . A total of 1943 (9,7%) study participants had baseline contraindications to at least one GDMT class. Among the 15575 patients without contraindications who completed all study visits, quadruple therapy coverage increased from 12% (before Visit 1) to 28,1% (after Visit 3) in the overall cohort, from 21,6% to 47,4% in HF with reduced ejection fraction (HFrEF), from 11,5% to 28,2% in HFrEF with mildly reduced EF (HFmrEF), and from 4,5% to 12,7% in HFpEF. Target GDMT doses were used in a small proportion of patients. Sixty (1,2%) patients with HFrEF received drugs with proven efficacy from all four GDMT classes at target doses by study completion. Patients’ age and sex, body mass index, systolic blood pressure and heart rate, comorbidities, cardiac resynchronization therapy, previous hospitalization with HF, duration and functional class of HF, and EF value were associated with the prescription of GDMT classes and higher doses. Conclusion . Contraindications to at least one GDMT class were identified in 9,7% of patients with HF. For patients without initial contraindications, an increase in quadruple therapy coverage was noted during the follow-up period, but titration and achievement of target doses were insufficient. Increasing awareness and overcoming therapeutic inertia of physicians are critically important for increasing the coverage of patients with HF with optimal therapy.

Authors

Institutions

Publication Details

Journal
Russian Journal of Cardiology
Published
2025-10-10
DOI
https://doi.org/10.15829/1560-4071-2025-6517
Primary Topic
Heart Failure Treatment and Management
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Use of guideline-directed medical therapy in outpatients with heart failure in real-world practice: a subanalysis of PRIORITY-HF study

Yu. N. Belenkov, Е. А. Медведева, О. Л. Барбараш, S. V. Villevalde et al.
Russian Journal of Cardiology
Heart Failure Treatment and Management
article

Use of guideline-directed medical therapy in outpatients with heart failure in real-world practice: a subanalysis of PRIORITY-HF study

Yu. N. Belenkov, Е. А. Медведева, О. Л. Барбараш, S. V. Villevalde, Е. V. Shlyakhto, Mareev VIu, И. В. Жиров, В. А. Невзорова, М. Г. Глезер, А. S. Galyavich, A. E. Soloveva, E. A. Zorina, С. Н. Терещенко, Н. Г. Виноградова, И. В. Фомин, Dmitry Viktorovich Duplyakov, O. M. Reitblat, Yu. M. Lopatin, Е. Д. Космачева, Zhanna Kobalava, S. А. Boytsov, Н. Э. Звартау
article en

Abstract

Material and methods. This retrospective analysis of contraindication rate to four GDMT classes was performed in 19981 outpatients with HF included in the PRIORITYHF study. The changes of drug prescription and titration were assessed in a cohort of patients without contraindications and who underwent visits at 6 and 12 months of follow-up. The multivariate mixed logistic regression was used to determine factors associated with the prescription and higher doses of GDMT drugs. R e sults . A total of 1943 (9,7%) study participants had baseline contraindications to at least one GDMT class. Among the 15575 patients without contraindications who completed all study visits, quadruple therapy coverage increased from 12% (before Visit 1) to 28,1% (after Visit 3) in the overall cohort, from 21,6% to 47,4% in HF with reduced ejection fraction (HFrEF), from 11,5% to 28,2% in HFrEF with mildly reduced EF (HFmrEF), and from 4,5% to 12,7% in HFpEF. Target GDMT doses were used in a small proportion of patients. Sixty (1,2%) patients with HFrEF received drugs with proven efficacy from all four GDMT classes at target doses by study completion. Patients’ age and sex, body mass index, systolic blood pressure and heart rate, comorbidities, cardiac resynchronization therapy, previous hospitalization with HF, duration and functional class of HF, and EF value were associated with the prescription of GDMT classes and higher doses. Conclusion . Contraindications to at least one GDMT class were identified in 9,7% of patients with HF. For patients without initial contraindications, an increase in quadruple therapy coverage was noted during the follow-up period, but titration and achievement of target doses were insufficient. Increasing awareness and overcoming therapeutic inertia of physicians are critically important for increasing the coverage of patients with HF with optimal therapy.

Russian Journal of CardiologyVol. 30(11S)
Privolzhsky Research Medical University (RU), Peoples' Friendship University of Russia (RU), Volgograd State Medical University (RU), Sechenov University (RU), Kazan State Medical University (RU), Vladivostok State Medical University (RU), Lomonosov Moscow State University (RU), Federal Almazov North-West Medical Research Centre (RU), Clinical Hospital No. 8 (RU), AstraZeneca (Singapore) (SG), Samara State Medical University (RU), National Medical Research Center of Cardiology (RU), Moscow State University (TJ), Kemerovo State University (RU)
Openalex Percentile: Top 57%
Heart Failure Treatment and Management
DOIOpen Access PDFOpenAlex
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.